NASDAQ:DYAX - Dyax Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Dyax Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume5.25 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Dyax Corp is a biopharmaceutical company. The Company is focused on Hereditary Angioedema (HAE) and other Plasma-Kallikrein-Mediated (PKM) Disorders, and licensing and funded research portfolio. The Company develops and commercializes treatments for hereditary angioedema. The Company discovered and developed KALBITOR, a plasma kallikrein inhibitor, and is selling it in the United States for the treatment of acute attacks of HAE. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A Current SymbolNASDAQ:DYAX Previous Symbol CUSIP26746E10 CIK907562 Webhttp://www.dyax.com/ Phone+1-617-2505769Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive DYAX News and Ratings via Email Sign-up to receive the latest news and ratings for DYAX and its competitors with MarketBeat's FREE daily newsletter. Dyax (NASDAQ:DYAX) Frequently Asked Questions What is Dyax's stock symbol? Dyax trades on the NASDAQ under the ticker symbol "DYAX." How were Dyax's earnings last quarter? Dyax Corp. (NASDAQ:DYAX) announced its earnings results on Wednesday, October, 28th. The biopharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.08). The biopharmaceutical company had revenue of $24.70 million for the quarter, compared to analyst estimates of $24.96 million. The firm's revenue for the quarter was up 12.3% on a year-over-year basis. During the same period last year, the firm earned ($0.01) earnings per share. View Dyax's Earnings History. Has Dyax been receiving favorable news coverage? Media coverage about DYAX stock has trended very negative recently, InfoTrie reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Dyax earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the biopharmaceutical company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Dyax. Who are some of Dyax's key competitors? Some companies that are related to Dyax include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), Alexion Pharmaceuticals (ALXN), Seattle Genetics (SGEN), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and Exelixis (EXEL). What other stocks do shareholders of Dyax own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dyax investors own include Kraft Foods Group (KRFT), Prudential (PRU), Standard Chartered (STAN), ASML (ASML), Novavax (NVAX), Dow Chemical (DOW), Dover Motorsports (DVD), Bank of Nova Scotia (BNS), Ariad Pharmaceuticals (ARIA) and BioDelivery Sciences International (BDSI). What is Dyax's official website? The official website for Dyax is http://www.dyax.com/. How can I contact Dyax? Dyax's mailing address is 55 Network Dr, BURLINGTON, MA 01803-2756, United States. The biopharmaceutical company can be reached via phone at +1-617-2505769. MarketBeat Community Rating for Dyax (NASDAQ DYAX)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 218 (Vote Outperform)Underperform Votes: 160 (Vote Underperform)Total Votes: 378MarketBeat's community ratings are surveys of what our community members think about Dyax and other stocks. Vote "Outperform" if you believe DYAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DYAX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2020 by MarketBeat.com StaffFeatured Article: VIX - Volatility Index
